NO20082915L - Sulfamoylsulfonat-prodrug - Google Patents

Sulfamoylsulfonat-prodrug

Info

Publication number
NO20082915L
NO20082915L NO20082915A NO20082915A NO20082915L NO 20082915 L NO20082915 L NO 20082915L NO 20082915 A NO20082915 A NO 20082915A NO 20082915 A NO20082915 A NO 20082915A NO 20082915 L NO20082915 L NO 20082915L
Authority
NO
Norway
Prior art keywords
sulfamoylsulfonat
prodrug
compounds
sulfamoylsulfonate
prodrugs
Prior art date
Application number
NO20082915A
Other languages
English (en)
Norwegian (no)
Inventor
Ralf Wyrwa
Rheinhard Nubbemeyer
Ursula Ganzer
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of NO20082915L publication Critical patent/NO20082915L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO20082915A 2005-11-30 2008-06-27 Sulfamoylsulfonat-prodrug NO20082915L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005057408A DE102005057408A1 (de) 2005-11-30 2005-11-30 Sulfamoylsulfonat-Prodrugs
PCT/EP2006/011726 WO2007062874A2 (de) 2005-11-30 2006-11-27 Sulfamoylsulfonat-prodrugs

Publications (1)

Publication Number Publication Date
NO20082915L true NO20082915L (no) 2008-06-27

Family

ID=37983623

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082915A NO20082915L (no) 2005-11-30 2008-06-27 Sulfamoylsulfonat-prodrug

Country Status (15)

Country Link
EP (1) EP1957513A2 (es)
JP (1) JP2009517424A (es)
KR (1) KR20080072956A (es)
CN (1) CN101316858A (es)
AU (1) AU2006319380A1 (es)
BR (1) BRPI0619253A2 (es)
CA (1) CA2632272A1 (es)
CR (1) CR10003A (es)
DE (1) DE102005057408A1 (es)
EA (1) EA200801306A1 (es)
EC (1) ECSP088489A (es)
IL (1) IL191570A0 (es)
NO (1) NO20082915L (es)
WO (1) WO2007062874A2 (es)
ZA (1) ZA200805659B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG174483A1 (en) * 2009-03-24 2011-10-28 Univ Singapore Use of artemisinin derivatives for the treatment of asthma and chronic obstructive pulmonary disease (copd)
CN101987101A (zh) * 2009-08-05 2011-03-23 天津金耀集团有限公司 糖皮质激素芳香基氨磺酰基磺酸酯为活性成分的眼用抗炎组合物
CN101987104A (zh) * 2009-08-05 2011-03-23 天津金耀集团有限公司 一种杂芳香基氨磺酰基羧酸酯碳酸酐酶抑制剂的眼用组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE102004025985A1 (de) * 2004-05-21 2005-12-15 Schering Ag Estriol- und Estetrol-Prodrugs
DE102004025966A1 (de) * 2004-05-21 2005-12-15 Schering Ag Estradiol-Prodrugs
DE102004025986A1 (de) * 2004-05-21 2005-12-15 Schering Ag Steroid-Prodrugs mit androgener Wirkung

Also Published As

Publication number Publication date
ECSP088489A (es) 2008-06-30
KR20080072956A (ko) 2008-08-07
WO2007062874B1 (de) 2007-09-27
WO2007062874A3 (de) 2007-07-12
CR10003A (es) 2008-08-21
IL191570A0 (en) 2008-12-29
WO2007062874A2 (de) 2007-06-07
AU2006319380A1 (en) 2007-06-07
CA2632272A1 (en) 2007-06-07
BRPI0619253A2 (pt) 2011-09-27
EP1957513A2 (de) 2008-08-20
JP2009517424A (ja) 2009-04-30
DE102005057408A1 (de) 2007-05-31
ZA200805659B (en) 2009-10-28
CN101316858A (zh) 2008-12-03
EA200801306A1 (ru) 2008-10-30

Similar Documents

Publication Publication Date Title
JOP20180109A1 (ar) تركيبة جديدة
TW200800999A (en) Novel compounds
NO20090628L (no) Pyridizinon derivativater
TW200745114A (en) Novel compounds
NO20084256L (no) DPP IV inhibitorformuleringer
NO20091603L (no) Kjemiske forbindelser
TW200745084A (en) Novel compounds
TW200716606A (en) Chemical compounds
TW200800963A (en) Chemical compounds
SI1853602T1 (sl) Kemične spojine
SI1853588T1 (sl) Kemične spojine
NO20092412L (no) Hydantoinderivater anvendes som MMP-inhibitorer
DK2036892T3 (da) 1,2,4,5-tetrahydro-3H-benzazepinforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
NO20070570L (no) Forbindelser.
WO2009013545A3 (en) Chemical compounds
NO20073631L (no) Metasubstituerte tiazolidinoner, fremgangsmate for fremstilling og anvendelse av disse som legemiddel
DK1670778T3 (da) Omlejrede pentanoler, en fremgangsmåde til fremstilling heraf og anvendelse heraf som betændelsehæmmende
NO20091935L (no) Nye krystalliske former
NO20064034L (no) Makrolider og fremgangsmater for a fremstille disse
GB0508314D0 (en) Organic compounds
NO20064351L (no) Caspaseinhibitorer og anvendelser derav
SE0403086D0 (sv) Compounds
NO20074528L (no) Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme
MY150497A (en) New camptothecin analogue compounds, a process for their preparation and pharmaceutical compositions containing them
IL191670A0 (en) Compounds for the inhibition of apoptosis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application